Form 4: United Therapeutics Director Sells Shares

Nilda Mesa, a Director at United Therapeutics Corp., reported the sale of 258 shares of common stock on May 12, 2026, for $581.935 per share.

Summary

• Nilda Mesa, a Director at United Therapeutics Corp. (UTHR), has reported a transaction involving company stock.
• On May 12, 2026, Mesa sold 258 shares of common stock.
• The sale was executed at a price of $581.935 per share.
• Following this transaction, Mesa beneficially owns 5,028 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine disclosure of a director's stock sale without additional context that would suggest strong positive or negative sentiment.

Negatives

• A director has sold a portion of their holdings in the company.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the buying and selling activities of company directors and officers. Such transactions can sometimes be interpreted by the market as signals regarding management's confidence in the company's prospects.

Stakeholder Impact

• Shareholders may observe this transaction as a signal from a director, potentially influencing their perception of management's confidence in the company's future performance.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Stock Sale, United Therapeutics, UTHR, Director Transaction, Beneficial Ownership